IBA develops, manufactures and supports medical devices and software solutions for cancer treatment by proton beam therapy, for cancer diagnosis and for patient quality assurance (Dosimetry). In addition, the company partners with healthcare leaders to provide cancer clinics and academic health centers with a fully-integrated approach of the patient flow.
IBA will host a webcast conference call and Q&A session at 14.00 CET on Thursday, August 28 2014. Olivier Legrain, Chief Executive Officer, and Jean-Marc Bothy, Chief Financial Officer, will host the call, which will be conducted in English.
The conference call will be webcast live and may be accessed at:http://arkadinemea-events.adobeconnect.com/iba/
If you would like to participate in the Q&A, dial (PIN code 69403589#):
Shortly after the call, the presentation will be available on the Company's website.
august 28th, 2014